Literature DB >> 16200555

Treatment adherence and 6-mercaptopurine metabolites.

Paul S Gaynon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16200555     DOI： 10.1002/pbc.20620

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  2 in total

Review 1.  Special considerations for the treatment of multiple myeloma according to advanced age, comorbidities, frailty and organ dysfunction.

Authors:  Muhammad Asad Fraz; Faiza Hassan Warraich; Sami Ullah Warraich; Muhammad Junaid Tariq; Zabih Warraich; Ali Younas Khan; Muhammad Usman; Awais Ijaz; Pavan Tenneti; Adeela Mushtaq; Faisal Akbar; Zaina Shahid; Zeeshan Ali; Hafiz Muhammad Fazeel; Cesar Rodriguez; Aboo Nasar; Ali McBride; Faiz Anwer
Journal:  Crit Rev Oncol Hematol       Date:  2019-02-27       Impact factor: 6.312

2.  When Multiple Objective Measures of Medication Adherence Indicate Incongruent Adherence Results: An Example with Pediatric Cancer.

Authors:  Caitlin J Cain; Andrea R Meisman; Kirstin Drucker; Evrosina I Isaac; Tanvi Verma; Jordyn Griffin; Jennifer M Rohan
Journal:  Int J Environ Res Public Health       Date:  2020-03-17       Impact factor: 3.390
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.